FDA grants orphan drug designation to APX005M for three cancer types

The FDA granted orphan drug designation to APX005M for the treatment of three gastrointestinal cancer types, according to the agent’s manufacturer.

https://www.healio.com/news/hematology-oncology/20201019/fda-grants-orphan-drug-designation-to-apx005m-for-three-cancer-types

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *